Trials / Terminated
TerminatedNCT06975891
Performance of Systane PRO Versus Refresh Optive Mega-3
Subjective and Objective Performance of Systane PRO Versus Refresh Optive Mega-3 in Dry Eye Patients
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Scripps Poway Eyecare and Optometry · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Single site, prospective, double-masked, randomized-controlled, cross-over study of the subjective and objective performance of 2 different eyedrops. Subjects will be assessed at a screening visit, and 3 follow-up visits. Clinical evaluations will include patient questionnaires.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Systane PRO | Lubricating Eyedrops |
| DRUG | Refresh Optive MEGA-3 | Lubricating Eyedrops |
Timeline
- Start date
- 2025-05-15
- Primary completion
- 2025-09-30
- Completion
- 2025-09-30
- First posted
- 2025-05-16
- Last updated
- 2026-04-13
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06975891. Inclusion in this directory is not an endorsement.